Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) shares were up 5.2% on Monday . The stock traded as high as $28.58 and last traded at $28.46. Approximately 208,472 shares changed hands during mid-day trading, a decline of 71% from the average daily volume of 708,890 shares. The stock had previously closed at $27.06. Analyst […]
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Releases Earnings Results, Misses Expectations By $0.82 EPS kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) has been assigned a consensus recommendation of “Buy” from the eight ratings firms that are covering the stock, MarketBeat reports. Eight analysts have rated the stock with a buy rating. The average 1 year price objective among analysts that have issued ratings on the stock in the last […]
Zentalis Pharmaceuticals (NASDAQ:ZNTL – Get Rating) had its price target hoisted by Stifel Nicolaus from $45.00 to $50.00 in a research report sent to investors on Wednesday, The Fly reports. Other equities analysts also recently issued research reports about the stock. Wedbush raised their target price on shares of Zentalis Pharmaceuticals from $31.00 to $38.00 […]
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) insider Kevin D. Bunker sold 80,000 shares of the company’s stock in a transaction that occurred on Friday, May 26th. The shares were sold at an average price of $30.02, for a total value of $2,401,600.00. Following the completion of the sale, the insider now owns 15,000 shares […]